|
UPSI Digital Repository (UDRep)
|
|
| ||||||||||||||||||
| Full Text : |
| Clinical history, morphological appearance and cytogenetic data are required in identifying cases of MyelodysplasticSyndrome (MDS). However, this clonal stem cell disorder is still widely heterogenous and multiple tools are utilized in determining the diagnosis and prognosis. The current approaches in diagnosis are inherently subjective and lack of sensitivity. Over the years, altered maturation patterns using flow cytometry analysis have been reported to be useful for identification of MDS. This systematic review aims to assess the sensitivity of maturation pattern in obtaining MDS diagnosis. Electronic databases (MEDLINE, PROQUEST, OVID, Scopus, Web of Science) searched were yielded 677 articles. Snowballing was also employed. Two reviewers assessed each article independently using the following inclusion criteria: all types of MDS; WHO or FAB classification; diagnosis; immunophenotyping. Nineteen papers that met our inclusion criteria were analysed on the maturation pattern using flow cytometry. Samples used were bone marrow aspiration and prepared using either whole blood lysis or Ficoll-density gradient centrifugation. The most studied lineage in diagnosing MDS using maturation pattern is myeloid mainly looking on the CD34+, CD11b/CD16, CD13/CD16 and CD235a/CD71 expression pattern. Five studies showed sensitivity between 70 to 98 percent. Maturation pattern has shown high sensitivity and may be used as an ancillary technique for the diagnosis of MDS. However, flow cytometry strategies employed lack of standardization in assay, scoring system, and on how flow cytometry data have been analysed. Thus, more study need to be done within laboratory and multi-centre study to ensure validity and reliability of maturation pattern as an adjunct test. |
| References |
1. Bejar, R., & Steensma, D. P. (2014). Recent developments in myelodysplastic syndromes. Blood, 124(18), 2793-2803.
2. Boroojerdi, M. H., Daneshvar, N., Ghoraishizadeh, P., Noor, S. M., Seman, Z., & Ramasamy, R. (2013). Descriptive analysis of antigen expression pattern in refractory anemia, refractory anemia with ringed sideroblasts and refractory anemia with excess blast cases using flow cytometry. Journal of Medicine & Biomedical Sciences, 4(2).
3. Broojerdi, M. H., Ramasamy, R., Noor, S. M., & Seman, Z. B. (2012). Qualitative flow cytometric analysis of Malaysian myelodysplastic syndromes (MDS) patients. Medical Journal of Malaysia, 67(1), 77.
4. Chopra, A., Pati, H., Mahapatra, M., Mishra, P., Seth, T., Kumar, S., . . . Kumar, R. (2012). Flow cytometry in
myelodysplastic syndrome: analysis of diagnostic utility using maturation pattern-based and quantitative approaches. Annals of Hematology, 91(9), 1351-1362.
5. Chung, J.-W., Park, C.-J., Cha, C.-H., Cho, Y.-U., Jang, S., Chi, H.-S., . . . Lee, K.-H. (2012). A combination of CD15/CD10, CD64/CD33, CD16/CD13 or CD11b flow cytometric granulocyte panels is sensitive and specific for diagnosis of myelodysplastic syndrome. Annals of Clinical & Laboratory Science, 42(3), 271-280.
6. Craig, F. E., & Foon, K. A. (2008). Flow cytometric immunophenotyping for hematologic neoplasms. Blood, 111(8), 3941- 3967.
7. De Smet, D., Trullemans, F., Jochmans, K., Renmans, W., Smet, L., Heylen, O., . . . De Waele, M. (2012). Diagnostic potential of CD34+ cell antigen expression in myelodysplastic syndromes. American Journal of Clinical Pathology, 138(5), 732-743.
8. Della Porta, M., Malcovati, L., Invernizzi, R., Travaglino, E., Pascutto, C., Maffioli, M., . . . Vanelli, L. (2006). Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome. Leukemia, 20(4), 549-555.
9. DeZern, A. E., & Sekeres, M. A. (2014). The challenging world of cytopenias: distinguishing myelodysplastic syndromes from other disorders of marrow failure. The Oncologist, 19(7), 735-745.
10. Hanumanthu, V. S., & Pirruccello, S. J. (2013). GCSF-R expression in myelodysplastic and myeloproliferative disorders and blast dysmaturation in CML. American Journal of Clinical Pathology, 140(2), 155-164.
11. Kalina, T., Flores-Montero, J., Van Der Velden, V., Martin-Ayuso, M., Böttcher, S., Ritgen, M., . . . Mendonca, A. (2012). EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols. Leukemia, 26(9), 1986-2010.
12. Kern, W., Haferlach, C., Schnittger, S., Alpermann, T., & Haferlach, T. (2013). Serial assessment of suspected myelodysplastic syndromes: significance of flow cytometric findings validated by cytomorphology, cytogenetics, and molecular genetics. Haematologica, 98(2), 201-207.
13. Kern, W., Haferlach, C., Schnittger, S., & Haferlach, T. (2010). Clinical utility of multiparameter flow cytometry in the diagnosis of 1013 patients with suspected myelodysplastic syndrome. Cancer, 116(19), 4549-4563.
14. Killick, S. B., Carter, C., Culligan, D., Dalley, C., Das‐Gupta, E., Drummond, M., . . . Mills, J. (2014). Guidelines for the diagnosis and management of adult myelodysplastic syndromes. British Journal of Haematology, 164(4), 503-525.
15. Kussick, S. J., Fromm, J. R., Rossini, A., Li, Y., Chang, A., Norwood, T. H., & Wood, B. L. (2005). Four-color flow cytometry shows strong concordance with bone marrow morphology and cytogenetics in the evaluation for
myelodysplasia. American Journal of Clinical Pathology, 124(2), 170-181.
16. Lorand-Metze, I., Ribeiro, E., Lima, C. S., Batista, L. S., & Metze, K. (2006). Detection of hematopoietic maturation abnormalities by flow cytometry in myelodysplastic syndromes and its utility for the differential diagnosis with non-clonal disorders. Leukemia Research, 31(2), 147-155.
17. Maftoun-Banankhah, S., Maleki, A., Karandikar, N. J., Arbini, A. A., Fuda, F. S., Wang, H.-Y., & Chen, W. (2008). Multiparameter flow cytometric analysis reveals low percentage of bone marrow hematogones in myelodysplastic syndromes. American Journal of Clinical Pathology, 129(2), 300-308.
18. Malcovati, L., Della Porta, M., Lunghi, M., Pascutto, C., Vanelli, L., Travaglino, E., . . . Invernizzi, R. (2005). Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome. Leukemia, 19(5), 776-783.
19. Matarraz, S., Lopez, A., Barrena, S., Fernández, C., Jensen, E., Flores, J., . . . Sánchez, M. (2008). The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+; hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursors. Leukemia, 22(6), 1175-1183.
20. Mathis, S., Chapuis, N., Debord, C., Rouquette, A., Radford-Weiss, I., Park, S., . . . Kosmider, O. (2013). Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes. Leukemia, 27(10), 1981-1987.
21. Monaghan, S. A., Surti, U., Doty, K., & Craig, F. E. (2012). Altered neutrophil maturation patterns that limit
identification of myelodysplastic syndromes. Cytometry Part B: Clinical Cytometry, 82(4), 217-228.
22. Mufti, G. J., Bennett, J. M., Goasguen, J., Bain, B. J., Baumann, I., Brunning, R., . . . Hellström-Lindberg, E. (2008). Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts. Haematologica, 93(11), 1712-1717.
23. Pirruccello, S. J., Young, K. H., & Aoun, P. (2006). Myeloblast phenotypic changes in myelodysplasia CD34 and CD117 expression abnormalities are common. American Journal of Clinical Pathology, 125(6), 884-894.
24. Porwit, A., van de Loosdrecht, A., Bettelheim, P., Brodersen, L. E., Burbury, K., Cremers, E., . . . Matarraz, S. (2014). Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes—proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS. Leukemia, 28(9), 1793-1798.
25. Reis-Alves, S., Traina, F., Metze, K., & Lorand-Metze, I. (2015). Improving the differential diagnosis between myelodysplastic syndromes and reactive peripheral cytopenias by multiparametric flow cytometry: the role of Bcell precursors. Diagnostic Pathology, 10(1), 44-44.
26. Stachurski, D., Smith, B. R., Pozdnyakova, O., Andersen, M., Xiao, Z., Raza, A., . . . Wang, S. A. (2008). Flow cytometric analysis of myelomonocytic cells by a pattern recognition approach is sensitive and specific in diagnosing myelodysplastic syndrome and related marrow diseases: emphasis on a global evaluation and recognition of diagnostic pitfalls. Leukemia Research, 32(2), 215-224.
27. Stetler-Stevenson, M., Arthur, D. C., Jabbour, N., Xie, X. Y., Molldrem, J., Barrett, A. J., . . . Rick, M. E. (2001). Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome. Blood, 98(4), 979-987.
28. Stetler-Stevenson, M., & Yuan, C. (2009). Myelodysplastic syndromes: the role of flow cytometry in diagnosis and prognosis. International Journal of Laboratory Hematology, 31(5), 479-483.
29. Vikentiou, M., Psarra, K., Kapsimali, V., Liapis, K., Michael, M., Tsionos, K., . . . Papasteriades, C. (2009). Distinct neutrophil subpopulations phenotype by flow cytometry in myelodysplastic syndromes. Leukemia & Lymphoma, 50(3), 401-409.
30. Westers, T. M., van der Velden, V. H., Alhan, C., Bekkema, R., Bijkerk, A., Brooimans, R. A., . . . Homburg, C. (2012). Implementation of flow cytometry in the diagnostic work-up of myelodysplastic syndromes in a multicenter approach: report from the Dutch Working Party on Flow Cytometry in MDS. Leukemia Research, 36(4), 422-430. |
| This material may be protected under Copyright Act which governs the making of photocopies or reproductions of copyrighted materials. You may use the digitized material for private study, scholarship, or research. |